WE FIGHT MALARIA 24/7/365.
Last year, malaria killed more than 1,000 children EVERY DAY.
The world needs a highly effective vaccine to help eliminate malaria globally.
To aid this effort, we and our collaborators study animals and humans immunized
with Plasmodium sporozoites to decipher protective immune responses, identify
key proteins expressed by the parasite and create more effective vaccines.
We also develop ultrasensitive diagnostic tests to support malaria clinical trials & field studies.
With the Seattle Malaria Clinical Trials Center, we also perform Controlled Human
Malaria Infection studies to test new drugs and vaccines in human clinical trials.
The world needs a highly effective vaccine to help eliminate malaria globally.
To aid this effort, we and our collaborators study animals and humans immunized
with Plasmodium sporozoites to decipher protective immune responses, identify
key proteins expressed by the parasite and create more effective vaccines.
We also develop ultrasensitive diagnostic tests to support malaria clinical trials & field studies.
With the Seattle Malaria Clinical Trials Center, we also perform Controlled Human
Malaria Infection studies to test new drugs and vaccines in human clinical trials.
AND NOW WE FIGHT SARS-COV-2 AS WELL!
In March 2020, we initiated a T cell-focused vaccine project to fight the SARS-CoV-2 virus. In the first month of our project, we designed and produced several candidate vaccines and began testing these in mice early April 2020. Watch the video below and find out more here too!
Thanks for exploring our work.
Quick links:
Our Research - Publications - Contact us - Fund our research
Twitter: @WeFightMalaria
Homepage photo below: The lab group in the SLU E/F Building Courtyard
Left to right: Sean, Mariko, Brad, Jokichi, Nahum, Kurtis, Chaitra, Irene
